Local and national data show AI skills appearing in more job ads; Atlanta programs and bootcamps are racing to upskill workers. Experts say clarity and training will matter most.

Intrust IT opened a Brentwood office after joining Nashville-based 3LS, bringing its employee-owned MSP model to Middle Tennessee and creating cross-region opportunities for sister companies eyeing Cincinnati.

Texas Attorney General Ken Paxton sued Netflix, alleging the streamer secretly harvested Texans’ data — including kids’ viewing logs — and shared it with ad-tech and data brokers.

Knightwerx relocated its headquarters from Camarillo to Scottsdale as it ramps up drone production. The move puts the startup in the Phoenix metro’s growing manufacturing corridor.

Andromeda Ventures — led by former NASA executives — has joined UCF’s business incubator to speed dual‑use startups toward validation and government markets.

An LLM‑backed analysis finds D.C. and Maryland among the most exposed to AI‑driven task changes, and regional training programs are racing to respond.

UT San Antonio won a five-year, $44M NHLBI contract to expand the RURAL Cohort Study and bring a mobile clinic back to rural counties across four Southern states.

The NSF has suspended multiple UC Berkeley awards — including funding for a mixed‑reality Ohlone exhibit at the Lawrence Hall of Science — days before a mid‑May launch, renewing legal and budget fights on campus.

Akamai disclosed a seven‑year, $1.8B cloud commitment; reporting identifies Anthropic as the buyer and shares jumped sharply on the news.

UC San Diego researchers built T1GRS, a machine‑learning genetic score that finds more people at risk for type 1 diabetes and reveals four genetic subtypes.

ASU and Mayo Clinic in Arizona are testing blood and immune markers to detect colorectal cancer earlier, with a special focus on younger adults. The work pairs ASU engineers with Mayo clinicians to move promising tests toward clinical trials.

Salk researchers say certain B cells can find tumors and call in T cells — an early, discovery‑stage finding that could widen immunotherapy options for solid cancers.

San Francisco’s Parker Institute is reorganizing to move more research toward companies and patients, adding senior marketing and communications hires under CEO Karen Knudsen.